Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Data Analysis”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,369 records · Page 76Linked to original sources
PubMed1992

Categorical data analysis in primary care research: log-linear models.

Primary care researchers often wish to perform multiple variable analyses using variables measured at a nominal or ordinal level. This paper provides a step-by-step description of log-linear modeling, an approach uniquely well suited to explore and describe interactions among three or more nominal or ordinal variables. The method of log-linear analysis is illustrated with the use of an example from a primary care research project in which the relationships among hypertension, diet, and sodium were examined. The advantages and disadvantages of log-linear models and logistic regression are compared and available computer software programs discussed.

Humans↗
PubMedDate not supplied

[Data analysis and quality control in radioimmunoanalysis. II. Evaluation of the internal and external quality in the quantification of pituitary gonadotropins].

The procedures for a systematic evaluation of the quality control of radioimmunoassay in general were described previously. In this report we present the parameters of quality control and their application to the radioimmunoassay (RIA) of pituitary gonadotrophic hormones, luteinizing hormone (LH) and follicle stimulating hormone (FSH) in serum. We present the results obtained in the intra-assay variation for the measurement of the pituitary gonadotrophic hormones in serum (LH and FSH) from 1983 to 1989. The results on bias and the inter-laboratory assessment through an external quality control scheme during the same period are also presented.

Bias↗
PubMed1990

GM1 gangliosides in the treatment of spinal cord injury: report of preliminary data analysis.

A prospective, randomized, placebo-controlled, double-blinded spinal cord injury GM1 ganglioside drug trial was completed. Of the 37 patients entered over a 16 month period, 34 patients (23 cervical and 11 thoracic injuries) received the test drug protocol and completed the one year follow up period. The neurologic recovery was quantified by serial measurement of the ASIA motor score throughout the acute hospital course and one year long follow up period. The primary variable used to assess neurologic recovery was the difference in the ASIA motor score from the admission value to the value at one year. The GM1 group had an average motor recovery of 36.9 points whereas the placebo group had an average change of 21.6 points (t-test difference, p = 0.088). Analysis of the secondary variable, the area under the ASIA motor score versus the logarithm of time, and the use of rank order nonparametric statistic on both the primary and secondary variables to sort neurologic recovery obtained similar statistical differences between the GM1 and placebo treatment groups. Randomization imbalances in baseline severity of injury and division of cervical and thoracic injury occurred in the trial. Because of this fact and the small sample size of the study verification of these results by a larger study is required.

Double-Blind Method↗